1. Fengjiao Bu, Yong-Soon Cho, Qingfeng He, Xiaowen Wang, Saurav Howlader, Dong-Hyun Kim, Mingshe Zhu, Jae Gook Shin, Xiaoqiang Xiang. Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim byUsing Physiologically Based Pharmacokinetic Modeling. Drug Design, Development and Therapy, 2024 Oct 15:18:4585-4600. doi: 10.2147/DDDT.S480402.
2. Saurav Howlader, Min-Jung Kim, M. Rasheduzzaman Jony, Nguyen Phuoc Long, Yong-Soon Cho, Dong-Hyun Kim, Jae-Gook Shin. Characterization of clofazimine metabolism in human liver microsomal incubation in vitro. Antimicrobial Agents and Chemotherapy. 2022 Oct 18;66(10):e0056522. doi: 10.1128/aac.00565-22.
3. Rahima Begum, Saurav Howlader, A N M Mamun-Or-Rashid, S M Rafiquzzaman, Ghulam Md Ashraf, Ghadeer M Albadrani, Amany A Sayed, Ilaria Peluso, Mohamed M Abdel-Daim, Md Sahab Uddin. Antioxidant and Signal-Modulating Effects of Brown Seaweed-Derived Compounds against Oxidative Stress-Associated Pathology. Oxidative Medicine and Cellular Longevity. 2021 Jul 10:2021:9974890. doi: 10.1155/2021/9974890.
4. Jae Sue Choi, Saurav Howlader, Subash Karki, Hee Jin Jung, Hyeung Rak Kim, Hyun Ah Jung. Acetyl- and butyryl-cholinesterase inhibitory activities of the edible brown alga Eisenia bicyclis. Archieve of Pharmacol Research. 2015 Aug;38(8):1477-87. doi: 10.1007/s12272-014-0515-1.
5. Rashid Tajbin, Zaman Sonia, Howlader Saurav, Siraji Ismail Hossain, and Jony Md. Rasheduzzaman. In vitro antioxidant activity of Antidesma bunius leaf extracts. Journal of Pharmacognosy and Phytochemistry, 2021; 10(3): 01-06, https://www.phytojournal.com/archives/2021/vol10issue3/PartA/10-2-288-878.pdf
6. Rajbongshi Lata, Rahman Azizur, Rahman Mizanur, Howlader Saurav. Extraction and in vitro screening of potential acetylcholinesterase, butyrylcholinesterase, and BACE1 inhibitors from the leaves of Ocimum sanctum. Indo American Journal of Pharmaceutical Sciences. 2017; 4(08); 2417-2424, https://www.academia.edu/34526564/28_IAJPS28082017_pdf
7. Ekramul Hasan, Rajbongshi Lata, Abdur Rouf, Howlader Saurav. In Vitro anti-diabetic and anti-inflammatory activity of Heliotropium indicum leaf extract in LPS-stimulated RAW264.7 Cells. Indo American Journal of Pharmaceutical Sciences, 2019; 06(04); 8745-8752
9. Ekramul Hasan, Rajbongshi Lata, Abdur Rouf, Howlader Saurav. Anti-nociceptive and anti-inflammatory activities of ethanolic extract of Xylocarpus granatum leaves. Indo American Journal of Pharmaceutical Sciences, 2019; 06(05); 9596-9602
10. Howlader Saurav, Rahman Azizur, Rahman Mizanur, Rajbongshi Lata, Rahman Mahfuz. Inhibitory activities of Ocimum sanctum and its flavonoid constituents on angiotensin-converting enzyme. Indo American Journal of Pharmaceutical Sciences, 2017; 4(10); 1-8
https://paper.researchbib.com/view/paper/138330
11. Howlader Saurav, Rajbongshi Lata, Hossain Farhad. Inhibitory activities of alkaloid from Coccinia grandis against aldose reductase and generation of advanced glycation end products. Indo American Journal of Pharmaceutical Sciences, 2017; 4(10); 1937-1943
1. Saurav Howlader. Characterization of Pyrazinamide metabolism in vitro: Insights into the role of the Aldehyde Oxidase and Xanthine Oxidase. The 26th North American Meeting of the International Society for the Study of Xenobiotics and the 39th Japanese Society for the Study of Xenobiotics (ISSX/JSSX), Honolulu, Hawaii, USA, 2024.
2. Saurav Howlader. Characterization of Pyrazinamide metabolism in vitro: Insights into the role of the Aldehyde Oxidase and Xanthine Oxidase. The Korean Society of Clinical Pharmacology and Therapeutics (KSCPT), Gyeongju, South Korea, 2023.
3. Saurav Howlader. The effect of clofazimine in modulating intracellular concentrations of remdesivir, nucleoside metabolite GS-441524, and triphosphate metabolite GS-443902: A potential mechanism of enhancing antiviral effects against SARS-CoV-2? in The 25th North American Meeting of the International Society for the Study of Xenobiotics (ISSX), Boston, USA, 2022.
4. Saurav Howlader. Characterization of the Cytochrome P450 enzymes involved in the metabolism of the anti-tuberculosis drug, Clofazimine. The Korean Society of Clinical Pharmacology (KOSPHAR), BEXCO, Busan, South Korea, 2021.
5. Saurav Holwader. Characterization of the Cytochrome P450 enzymes involved in the metabolism of the anti-tuberculosis drug, Clofazimine. The 132nd congress of the Korean Academy of Tuberculosis and Respiratory Diseases (KATRD), Seoul, South Korea, 2020.
6. Saurav Howlader. Characterization of the Cytochrome P450 enzymes involved in the metabolism of the anti-tuberculosis drug, Clofazimines. The American Society of Clinical Pharmacology and Therapeutics (ASCPT), Houston, USA, 2019.
7. Saurav Howlader. Assessment of the Drug Interaction Between Fixed-Dose Combination of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male Subjects. The Korean Society of Clinical Pharmacology and Therapeutics (KSCPT), Seoul, South Korea, 2018.
8. Saurav Howlader. Acetyl- and butyryl-cholinesterase inhibitory activities of the edible brown alga Eisenia bicyclis. The Second International Symposium for Molecular Neurodegenerative Disease research organized by the Korean Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea, 2014.
9. Saura Howlader. Characterization of the Cytochrome P450 enzymes involved in the metabolism of anti-tuberculosis drug, Clofazimine. The BK21 Plus Symposium, College of Medicine, Inje University, December 18, 2019, Busan, South Korea.
10. Saurav Howlader. Characterization of Clofazimine as a Potential Substrate of Drug Transporter. The BK21 Plus Symposium, College of Medicine, Inje University, December 18, 2019, Busan, South Korea.
1. 2020-2025 Medical Research Center Fellowship (Research Grant for PhD Thesis)
2. 2018-2020 Brain Korea 21 (BK21) Fellowship (Research Grant for PhD Thesis)
3. 2015-2016 National Research Foundation (NRF) Fellowship (Research grant for MS Thesis)
4. 2014-2015 Brain Korea 21 (BK21) Fellowship (Research grant for MS Thesis)
1. 2020 to 2025, Scholarship from Inje University, College of Medicine (Research-based full funded scholarship).
2. 2018 to 2020, Scholarship from Inje University, College of Medicine (Research-based full funded scholarship).
3. 2014 to 2016, Scholarship from Pukyong National University, College of Natural Sciences (Fully funded MS research support).
4. 2006 to 2010, Scholarship from Southeast University, School of Science (Merit-based scholarship).
1. Best Oral Presenter Award, The BK21 Plus Symposium, College of Medicine, Inje University, 2019, Busan, South Korea.
2. First Place (Champion), University-Level Quiz Competition, Southeast University
1. Member, International Society for the Study of Xenobiotics (ISSX), USA (August 2024 to present).
2. Member, American Society for Clinical Pharmacology and Therapeutics (ASCPT), USA (March 2019 to present).
3. Member, Korean Society for Clinical Pharmacology and Therapeutics (KSCPT), South Korea (March 201 to present).
4. Member, Korean Society of Pharmacology (KOSPHAR), South Korea (March 2021 to present).